Estados Unidos - inglês - NLM (National Library of Medicine)

deseret biologicals, inc. - brucella melitensis (unii: oqf85710lz) (brucella melitensis - unii:oqf85710lz) - brucella melitensis - fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, gut inflammation • for the temporary relief of symptoms including: • fever • sweats • malaise • headache • back pain • neck pain • malodorous sweat • gut inflammation these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Estados Unidos - inglês - NLM (National Library of Medicine)

prokim kagitcilik ve kimyevi maddeler limited sirketi - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic • hand wipes to decrease bacteria on the skin • recommended for repeated use • for use when soap and water are not available

Cingapura - inglês - HSA (Health Sciences Authority)

biomedix singapore pte. ltd. - clinical chemistry - the chlorochek chloridometer test system is intended for the quantitative in vitro diagnostic determination of chloride in human sweat using the principle of coulometric titration. sweat chloride measurements are used in the diagnosis of cystic fibrosis. it is for use in clinical laboratory settings

Estados Unidos - inglês - NLM (National Library of Medicine)

elite laboratories, inc. - dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi), amphetamine aspartate monohydrate (unii: o1zpv620o4) (amphetamine - unii:ck833kgx7e), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi), amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e) - dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets is indicated for the treatment of attention deficit hyperactivity disorder (adhd) and narcolepsy. a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv ® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. for the inattentive type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; fo

Estados Unidos - inglês - NLM (National Library of Medicine)

elite laboratories, inc. - trimipramine maleate (unii: 269k6498ld) (trimipramine - unii:6s082c9ndt) - trimipramine maleate capsules are indicated for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. in studies with neurotic outpatients, the drug appeared to be equivalent to amitriptyline in the less-depressed patients but somewhat less effective than amitriptyline in the more severely depressed patients. in hospitalized depressed patients, trimipramine and imipramine were equally effective in relieving depression. the use of maois intended to treat psychiatric disorders with trimipramine maleate or within 14 days of stopping treatment with trimipramine maleate is contraindicated because of an increased risk of serotonin syndrome. the use of trimipramine maleate within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting trimipramine maleate in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also co

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ionics australasia pty ltd - chlorine present as calcium hypochlorite hydrated - pool chlorine - swimming pool - algae | bacteria

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

invictus ops pty ltd - bixa orellana, quantity: 82.25 mg/g (equivalent: bixa orellana, qty 27.41 g/g); silicon dioxide, quantity: 17.31 mg/g - powder - excipient ingredients: mannitol; sucralose; macrogol 8000; modified food starch; flavour - decrease/reduce/relieve muscle pain/ache/soreness ; aid/assist/helps post exercise recovery ; helps enhance/improve muscle recovery time

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

elitechgroup australia pty ltd - 15128 - sweat-induction iontophoresis system - for the collection of sweat for subsequent analysis in the diagnosis of cystic fibrosis